UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000021831
Receipt number R000024414
Scientific Title Prospective, Multicenter, Observational Study for the Prognosis of patients with Heart Failure with Preserved Ejection Fraction
Date of disclosure of the study information 2016/04/07
Last modified on 2023/10/15 18:11:16

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prospective, Multicenter, Observational Study for the Prognosis of patients with Heart Failure with Preserved Ejection Fraction

Acronym

Prospective, Multicenter, Observational Study of Patients with Heart Failure with Preserved Ejection Fraction (PURSUIT-HFpEF)

Scientific Title

Prospective, Multicenter, Observational Study for the Prognosis of patients with Heart Failure with Preserved Ejection Fraction

Scientific Title:Acronym

Prospective, Multicenter, Observational Study of Patients with Heart Failure with Preserved Ejection Fraction (PURSUIT-HFpEF)

Region

Japan


Condition

Condition

Heart failure with preserved ejection fraction

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate patients with heart failure with preserved ejection fraction comprehensively

Basic objectives2

Others

Basic objectives -Others

To investigate patients' background, factors involved in the disease and the prognosis in patients with HFpEF, to clarify the mechanism of the disease and identify the predictors of the prognosis, and to provide new insight leading to development of diagnostics and treatments of HFpEF

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

survival from registration

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients hospitalized for heart failure (diagnosed by using Framingham criteria) who meet both of the following criteria:
a left ventricular ejection fraction of 50% or more as measured at the local site by means of echocardiography, and
an elevated level of N terminal pro brain natriuretic peptide (NT proBNP) (400 pg per milliliter or more) or brain natriuretic peptide (BNP)(100 pg per milliliter or more)

Key exclusion criteria

Patients with severe valvular heart disease including aortic stenosis, aortic regurgitation, mitral stenosis and mitral regurgitation; acute coronary syndrome; severe systemic illness except for cardiac disease with a life expectancy of less than 6 months; or after heart transplantation

Target sample size

1500


Research contact person

Name of lead principal investigator

1st name Yasushi
Middle name
Last name Sakata

Organization

Osaka University Graduate School of Medicine

Division name

Department of Cardiovascular Medicine

Zip code

565-0871

Address

2-2 Yamadaoka, Suita, Osaka, Japan

TEL

06-6879-3631

Email

yasushisk@cardiology.med.osaka-u.ac.jp


Public contact

Name of contact person

1st name Shungo
Middle name
Last name Hikoso

Organization

Osaka University Graduate School of Medicine

Division name

Department of Cardiovascular Medicine

Zip code

565-0871

Address

2-2 Yamadaoka, Suita, Osaka, Japan

TEL

06-6879-3631

Homepage URL


Email

hikoso@cardiology.med.osaka-u.ac.jp


Sponsor or person

Institute

Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Osaka university hospital

Address

2-15 Yamadaoka, Suita, Osaka, Japan

Tel

06-6210-8289

Email

rinri@hp-crc.med.osaka-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

大阪大学医学部附属病院(大阪府)、市立池田病院(大阪府)、NTT西日本大阪病院(大阪府)、国立病院機構大阪医療センター(大阪府)、大阪警察病院(大阪府)、大阪府立急性期・総合医療センター(大阪府)、大阪成人病センター(大阪府)、国立病院機構大阪南医療センター(大阪府)、大阪労災病院(大阪府)、加納総合病院(大阪府)、川崎病院(大阪府)、河内総合病院(大阪府)、市立川西病院(大阪府)、関西労災病院(兵庫県)、紀南病院(和歌山県)、公立学校共済組合 近畿中央病院(兵庫県)、兵庫県立西宮病院(兵庫県)、神戸掖済会病院(兵庫県)、大阪府済生会千里病院(大阪府)、桜橋渡辺病院(大阪府)、地域医療機能推進機構JCHO大阪病院(大阪府)、地域医療機能推進機構JCHO大阪みなと病院(大阪府)、地域医療機能推進機構JCHO星ヶ丘医療センター(大阪府)、市立吹田市民病院(大阪府)、住友病院(大阪府)、市立豊中病院(大阪府)、東大阪市立総合病院(大阪府)、箕面市立病院(大阪府)、八尾市立病院(大阪府)、りんくう総合医療センター(大阪府)


Other administrative information

Date of disclosure of the study information

2016 Year 04 Month 07 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2016 Year 02 Month 24 Day

Date of IRB

2016 Year 02 Month 24 Day

Anticipated trial start date

2016 Year 04 Month 28 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This study is an observational study using the prospectively maintained database. The subjects consist of all the patients who meet inclusion criteria and do not conflict with exclusion criteria. Patients' data are collected during hospitalization and every one year after discharge and patients are followed up to 5 years after discharge.


Management information

Registered date

2016 Year 04 Month 07 Day

Last modified on

2023 Year 10 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024414


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name